No abstract available
MeSH terms
-
Clinical Trials as Topic
-
Contraindications
-
Evidence-Based Medicine*
-
Guidelines as Topic*
-
Humans
-
Injections, Intravenous
-
Patient Selection
-
Stroke / drug therapy*
-
Thrombolytic Therapy*
-
Time Factors
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / therapeutic use
Substances
-
Tissue Plasminogen Activator